pharma · Uveal Melanoma · HLA-A2 negative metastatic uveal melanoma · IDYA
IDEAYA Biosciences
IDEAYA Biosciences trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.
5000 Shoreline Ct, Suite 300, South San Francisco, California 94080, US HQ
2015 Founded
248 Employees
Public company Type
IDYA · NYSE Ticker
Company details
- Status
- Public
- HQ
- 5000 Shoreline Ct, Suite 300, South San Francisco, California 94080, US
- Founded
- 2015
- Employees
- 248
- Programs
- 14
- Drugs
- 12
- Patents
- 12
IDEAYA Biosciences clinical trials
Registry index of 16 ClinicalTrials.gov studies linked to IDEAYA Biosciences programs — each row shows trial ID, program name, phase, status, and indication.
IDEAYA Biosciences trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for IDEAYA Biosciences.
-
IDE397-001 — Phase 1
Clinical update -
IDE196-009 — Phase 2
Clinical update -
IDE196-002 — Phase 3
Clinical update -
IDE196-002 — Phase 3
Clinical update -
IDE196 — Phase 3
Clinical update -
IDE196 (LXS196), IDE196 (LXS196) — Phase 3
Clinical update -
Darovasertib — Phase 3
Clinical update -
GSK4418959 — Phase 2
Clinical update